Form D · Other
TwoStep Therapeutics, Inc.
San Carlos, CA · CIK 0002015273
Offering snapshot reported Jan 20, 2026 · SEC filing
- Reported sold
- $21.1M Offering amount: $62.2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 9, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 20, 2026 | Initial | $21,109,518 | No comparison | 8 | SEC filing |
| Mar 18, 2024 | Initial | $6,499,998 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-570470
Series A Preferred Stock and Series A Preferred Stock issued upon conversion of existing convertible notes
Source: Form D, filed Jan 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Omri Amirav Drory | Director |
| Caitlyn Miller | Director, Executive, Promoter |
| Matias Porras Paniagua | Director |
| John Prufeta | Director |
Issuer details
Industry: Other (See others in industry)
Address:
733 Industrial Rd.
San Carlos, CA, 94070
San Carlos, CA, 94070